SNAP91 (Synaptosomal-Associated Protein 91, also known as AP180) is a neuronal clathrin adaptor protein essential for synaptic vesicle endocytosis. It is encoded by the SNAP91 gene on chromosome 6p21.1 and plays a critical role in clathrin coat assembly at the presynaptic membrane. The protein functions as a peripheral membrane protein that binds to clathrin, adaptor protein complex AP-2, and phosphoinositides to promote clathrin coat assembly during synaptic vesicle recycling. SNAP91 is expressed almost exclusively in neuronal tissues, with highest expression in the hippocampus, cortex, and cerebellar Purkinje cells. This page covers the gene's molecular function, protein structure, disease associations, expression patterns, and key research findings relevant to neurodegeneration and neurodevelopmental disorders. [1][2]
| Property | Value |
|---|---|
| Gene Symbol | SNAP91 |
| Alternative Names | AP180, SNAPAP, CLINT |
| Chromosomal Location | 6p21.1 |
| Ensembl ID | ENSG00000165655 |
| NCBI Gene ID | 10527 |
| UniProt ID | Q9Y5W7 |
| Protein Length | 923 amino acids |
| Molecular Weight | ~106 kDa |
The SNAP91 protein contains several distinct structural domains that mediate its function in synaptic vesicle endocytosis:
The N-terminal ANTH domain (approximately 300 amino acids) binds to phosphatidylinositol-4,5-bisphosphate (PIP2) on the presynaptic membrane. This domain is crucial for targeting SNAP91 to clathrin-coated pits and is structurally similar to the ENTH domain of epsin. The ANTH domain adopts a fold that creates a positively charged surface for lipid binding, facilitating membrane association during the early stages of vesicle formation.
SNAP91 contains multiple clathrin box motifs (LΦPΦXX, where Φ is a hydrophobic residue) that mediate binding to the clathrin terminal domain. These motifs allow SNAP91 to nucleate clathrin lattice assembly and stabilize the forming vesicle coat. The presence of multiple clathrin box motifs enables SNAP91 to simultaneously interact with multiple clathrin triskelia, promoting uniform coat assembly.
The central region of SNAP91 contains flexible linker sequences that connect the membrane-binding domain to the clathrin-interacting regions. These linkers allow the protein to span distances between the membrane and the clathrin coat, accommodating the geometry of forming vesicles.
The C-terminal region contains additional clathrin-binding motifs and is involved in dimerization, which may facilitate cooperative assembly of the clathrin coat.
Synaptic vesicles release neurotransmitters through exocytosis and must be efficiently recycled for continued neurotransmission. SNAP91 is a key player in the clathrin-mediated endocytosis (CME) pathway that recycles synaptic vesicles:
SNAP91 interacts with several key proteins in the synaptic vesicle recycling machinery:
SNAP91 exhibits highly restricted expression patterns:
| Tissue/Cell Type | Expression Level |
|---|---|
| Brain (hippocampus) | Very High |
| Cerebral Cortex | Very High |
| Cerebellum (Purkinje cells) | High |
| Striatum | Moderate |
| Brainstem | Moderate |
| Spinal Cord | Low-Moderate |
| Non-neuronal tissues | Very Low/Absent |
Within neurons, SNAP91 is concentrated in presynaptic terminals where it colocalizes with synaptic vesicles and other endocytic proteins. Its expression is largely restricted to excitatory glutamatergic neurons, with lower expression in GABAergic interneurons.
SNAP91 has emerged as a relevant player in Alzheimer's disease pathogenesis through several mechanisms:
Synaptic Dysfunction: SNAP91 expression and localization are altered in AD brains. The protein's role in synaptic vesicle recycling makes it vulnerable to the synaptic degeneration that characterizes AD. Altered SNAP91 function may contribute to impaired neurotransmitter release and synaptic failure.
APP Processing: SNAP91 interacts with amyloid precursor protein (APP) and influences its trafficking and proteolytic processing. Changes in SNAP91 levels may affect the amyloidogenic pathway that generates amyloid-beta peptides. The protein localizes to endocytic compartments where APP processing occurs, positioning it to influence amyloid production.
Amyloid-Beta Effects: Studies show that amyloid-beta oligomers can disrupt synaptic vesicle recycling machinery, potentially including SNAP91-mediated pathways. This creates a feed-forward loop where amyloid accumulation impairs synaptic function.
SNAP91 has been implicated in autism spectrum disorder through genetic and functional studies:
Genetic Findings: Rare variants in SNAP91 have been identified in individuals with ASD and intellectual disability. These variants may affect protein function, trafficking, or interactions with binding partners.
Synaptic Protein Networks: SNAP91 participates in synaptic protein interaction networks that are disrupted in ASD. The protein's role in maintaining synaptic homeostasis may be sensitive to perturbations that affect neural circuit function.
SNAP91 variants have been linked to non-syndromic intellectual disability, highlighting the importance of proper synaptic vesicle recycling for cognitive function. Loss-of-function mutations in SNAP91 are associated with impaired cognitive development. The protein's critical role in synaptic function explains its impact on learning and memory.
Altered SNAP91 expression has been reported in some forms of epilepsy, possibly related to impaired synaptic vesicle function and neurotransmitter release.
Drosophila melanogaster: The Drosophila homolog lap is essential for synaptic vesicle endocytosis. lap mutants show accumulation of clathrin-coated vesicles and severe synaptic transmission defects.
Mus musculus: Whole-body knockout is embryonic lethal. Brain-specific knockouts show impaired synaptic function, learning deficits, and age-dependent neurodegeneration phenotypes.
While SNAP91 is not a direct therapeutic target, understanding its function provides insights into: